The Effects of Oxcarbazepine and Valproate Therapies on Growth in Children with Epilepsy

REFERENCES

• Styne DM. The physiology of puberty. In: Brook CGD, ed. Clinical Pediatric Endocrinology. Oxford: Blackwell Science; 1995:234–252.
   Google Scholar
• Cansu A. Antiepileptic drugs and hormones in children. Epilepsy Res 2010;89:89–95.
   Google Scholar
• Cansu A, Serdaroğlu A, Camurdan O, . The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate. Epilepsia 2006;47:1855–1859.
   PubMed Web of Science ®Google Scholar
• Hirfanoglu T, Serdaroglu A, Camurdan O, . Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate. Pediatr Int 2007;49:822–826.
   PubMed Web of Science ®Google Scholar
• Cansu A, Yesilkaya E, Serdaroğlu A, . Evaluation of bone turnover in epileptic children using oxcarbazepine. Pediatr Neurol 2008;39:266–271.
   PubMed Web of Science ®Google Scholar
• Cansu A, Giray SG, Serdaroglu A, . Effects of chronic treatment with valproate and oxcarbazepine on ovarian folliculogenesis in rats. Epilepsia 2008;49:1192–1201.
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Laatikainen TJ, Knip M, . Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996;39:579–584.
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Rättyä J, Myllylä VV, . Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998;43:446–451.
   PubMed Web of Science ®Google Scholar
• Mattson RH, Cramer JA. Epilepsy, sex hormones, and antiepileptic drugs. Epilepsia 1985;26:S40–S51.
   PubMedGoogle Scholar
• Rättyä J, Vainionpää L, Knip M, . The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics 1999;103:588–593.
   PubMed Web of Science ®Google Scholar
• Kumandas S, Koklu E, Gümüs H, . Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3. J Pediatr Endocrinol Metab 2006;19:529–534.
   PubMed Web of Science ®Google Scholar
• El-Khayat HA, Aly GS, Tomoum HY, . Growth hormone levels in children and adolescents with epilepsy. Eur J Paediatr Neurol 2010;14:508–512.
   Google Scholar
• Gungor S, Yücel G, Akinci A, . The role of ghrelin in weight gain and growth in epileptic children using valproate. J Child Neurol 2007;22:1384–1388.
   PubMedGoogle Scholar
• Mikkonen K, Knip M, Pakarinen AJ, . Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation. Epilepsia 2005;46:1114–1120.
   PubMedGoogle Scholar
• Guo CY, Ronen GM, Atkinson SA. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia 2001;42:1141–1147.
   PubMed Web of Science ®Google Scholar
• El-Khayat HA, Abd El-Basset FZ, Tomoum HY, . Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy. Epilepsia 2004;45:1106–1115.
   PubMed Web of Science ®Google Scholar
• Kojima M, Hosoda H, Date Y, . Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656–660.
   PubMed Web of Science ®Google Scholar
• Bideci A, Camurdan MO, Cinaz P, . Ghrelin, IGF-I and IGFBP-3 levels in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2005;18:1433–1439.
   Google Scholar
• Greco R, Latini G, Chiarelli F, . Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid. Neurology 2005;65:1808–1809.
   PubMed Web of Science ®Google Scholar
• Prodam F, Bellone S, Casara G, . Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid. Epilepsia 2010;51:312–315.
   PubMed Web of Science ®Google Scholar
• Cansu A, Serdaroglu A, Cinaz P. Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving oxcarbazepine. Eur J Paediatr Neurol 2011;15:527–531.
   Google Scholar
• Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389–399.
   PubMed Web of Science ®Google Scholar
• Scheuer ML, Pedley TA. The evaluation and treatment of seizures. N Engl J Med 1990;323:1468–1474.
   PubMed Web of Science ®Google Scholar
• Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.
   PubMed Web of Science ®Google Scholar
• Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–23.
   PubMed Web of Science ®Google Scholar
• Neyzi O, Binyildiz P, Alp H. Growth standards for Turkish children: heights and weights. Courier 1979;29:553–558.
   Google Scholar
• Neyzi O, Furman A, Bundak R, . Growth references for Turkish children aged 6 to 18 years. Acta Paediatr 2006;95:1635–1641.
   PubMed Web of Science ®Google Scholar
• Turan S, Bereket A, Furman A, . The effect of economic status on height, insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in healthy Turkish children. Eur J Clin Nutr 2007;61:752–758.
   Google Scholar
• Bereket A, Turan S, Omar A, . Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: establishment of reference ranges with emphasis on puberty. Horm Res 2006;65:96–105.
   PubMedGoogle Scholar
• Coiro V, Capretti L, Bianconi L, . Reduction of baclofen-, but not sodium valproate-induced growth hormone release in type I diabetic men. Horm Metab Res 1991;23:600–604.
   PubMed Web of Science ®Google Scholar
• Whatmore AJ, Hall CM, Jones J, . Ghrelin concentrations in healthy children and adolescents. Clin Endocrinol (Oxf) 2003;59:649–654.
   PubMed Web of Science ®Google Scholar
• Edén Engström B, Burman P, Holdstock C, . Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. J Clin Endocrinol Metab 2003;88:5193–5198.
   Google Scholar
• Muller AF, Lamberts SW, Janssen JA, . Ghrelin drives GH secretion during fasting in man. Eur J Endocrinol 2002;146:203–207.
   PubMed Web of Science ®Google Scholar
• Nakazato M, Murakami N, Date Y, . A role for ghrelin in the central regulation of feeding. Nature 2001;409:194–198.
   PubMed Web of Science ®Google Scholar
• Wren AM, Seal LJ, Cohen MA, . Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992–5995.
   PubMed Web of Science ®Google Scholar
• Cansu A, Serdaroglu A, Camurdan O, . Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate. Horm Res Paediatr 2011;76:65–71.
   PubMedGoogle Scholar
• Aydin K, Serdaroglu A, Okuyaz C, . Serum insulin, leptin, and neuropeptide Y levels in epileptic children treated with valproate. J Child Neurol 2005;20:848–851.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Basciani F, Morresi S, . Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid. Neurology 1999;53:230–232.
   PubMed Web of Science ®Google Scholar
• Cummings DE, Weigle DS, Frayo RS, . Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623–1630.
   PubMed Web of Science ®Google Scholar